Does Rallies show Form 4 insider transactions for HCWB?

Yes. Rallies tracks HCWB insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is HCWB research on Rallies investment advice?

No. Rallies provides research, data, and educational context for HCWB. It does not provide personalized investment advice.

HCWB (HCW Biologics Inc. Common Stock) Stock Analysis - Insider Trades

HCW Biologics Inc. Common Stock (HCWB) is a publicly traded Healthcare sector company. As of May 21, 2026, HCWB trades at $2.05 with a market cap of $9.02M and a P/E ratio of -0.38. HCWB moved +133.49% today. Year to date, HCWB is +118.92%; over the trailing twelve months it is -73.53%. Its 52-week range spans $0.25 to $100.80. Analyst consensus is buy with an average price target of $2.00. Rallies surfaces HCWB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading HCWB stock inside the company?

Recent HCWB insider activity includes Wong Hing C bought 8.05K, Winer Gary M bought 1.34K, GARRETT SCOTT T bought 13.42K, Winer Gary M bought 2.31K, and Wong Hing C bought 92.50K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

HCWB Key Metrics

Key financial metrics for HCWB
Metric	Value
Price	$2.05
Market Cap	$9.02M
P/E Ratio	-0.38
EPS	$-7.73
Dividend Yield	0.00%
52-Week High	$100.80
52-Week Low	$0.25
Volume	1.38M
Avg Volume	0
Revenue (TTM)	$6.55M
Net Income	$-2.29M
Gross Margin	99.89%

Recent HCWB Insider Trades

Wong Hing C bought 8.05K (~$60.00K) on May 16, 2025.
Winer Gary M bought 1.34K (~$10.00K) on May 16, 2025.
GARRETT SCOTT T bought 13.42K (~$100.00K) on May 16, 2025.
Winer Gary M bought 2.31K (~$60.01K) on May 8, 2025.
Wong Hing C bought 92.50K (~$2.40M) on May 8, 2025.

Latest HCWB News

HCW Biologics EPS Beats, $6.54M Revenue on Licensing Fuel 122% Surge — May 15, 2026
HCW Biologics Q1 Delivers $6.5M Revenue, $3.5M Profit and $7M License Deal — May 14, 2026
HCW Biologics’ single-dose HCW11-040 prevents BPD in preclinical model — May 14, 2026
HCW Biologics' HCW11-018b shows novel cis-binding, shrinks tumors; IND due H1 2027 — Apr 27, 2026
HCW Biologics Nets $3.5M Upfront Fee, Launches HCW9302 Phase 1 Trial — Mar 31, 2026

HCWB Analyst Consensus

1 analysts cover HCWB: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $2.00.

Common questions about HCWB

Who is trading HCWB stock inside the company?: Recent HCWB insider activity includes Wong Hing C bought 8.05K, Winer Gary M bought 1.34K, GARRETT SCOTT T bought 13.42K, Winer Gary M bought 2.31K, and Wong Hing C bought 92.50K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for HCWB?: Yes. Rallies tracks HCWB insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is HCWB research on Rallies investment advice?: No. Rallies provides research, data, and educational context for HCWB. It does not provide personalized investment advice.